%0 Letter
%T Gastric microbiota transplantation as a potential treatment for immune checkpoint inhibitor-associated gastritis.
%A Ma BT
%A Sang LX
%A Chang B
%J World J Gastroenterol
%V 30
%N 24
%D 2024 Jun 28
%M 38983955
%F 5.374
%R 10.3748/wjg.v30.i24.3123
%X Immune-related adverse events (irAEs) are complications of the use of immune checkpoint inhibitors (ICIs). ICI-associated gastritis is one of the main irAEs. The gastric microbiota is often related to the occurrence and development of many gastric diseases. Gastric microbiota adjustment may be used to treat gastric disorders in the future. Faecal microbiota transplantation can alter the gut microbiota of patients and has been used for treating ICI-associated colitis. Therefore, we propose gastric microbiota transplantation as a supplementary treatment for patients with ICI-associated gastritis who do not respond well to conventional therapy.